Randolph Ngwafor

ORCID: 0000-0002-8749-9902
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Malaria Research and Control
  • Mosquito-borne diseases and control
  • Computational Drug Discovery Methods
  • Diverse Scientific Research Studies
  • Vaccine Coverage and Hesitancy
  • Viral Infections and Outbreaks Research
  • Virology and Viral Diseases
  • Hepatitis B Virus Studies
  • Immune responses and vaccinations
  • Drug-Induced Hepatotoxicity and Protection
  • Drug Transport and Resistance Mechanisms
  • Biological Research and Disease Studies
  • Cervical Cancer and HPV Research
  • Animal testing and alternatives

University of Oxford
2024

Université de Yaoundé I
2016-2024

University College London
2021

Ministry of Public Health
2019

African consumers and citizens are growingly aware of the wide range toxic poisoning scenarios from different products hazards. Recurrent episodes on that have been reported in Africa include hazards consumers’ ranging food to herbal medicine, drugs, cosmetics. Chemical remains an issue is overlooked by public health stakeholders Africa. Available information toxicovigilance systems practices countries reviewed terms increasing development, organization articulation levels. Less than nine...

10.3390/toxics4030013 article EN cc-by Toxics 2016-07-28

Introduction: Cervical cancer is the second most prevalent among women in Cameroon. In November 2020, HPV vaccine was introduced into expanded programme on immunisation. However, uptake of has been slow Centre region as opposed to other regions country. We therefore sought describe vaccinators' perception vaccination Saa health district. Methods: A self-administered questionnaire with both open-ended and closed questions used assess 24 vaccinators from Quantitative data were summarised...

10.3389/fpubh.2021.748910 article EN cc-by Frontiers in Public Health 2022-01-10

Background: Measles remains a threat in many African settings due to sub-optimal routine immunisation and catchup campaigns. The Global Vaccine Action Plan goal eliminate measles by 2020 unmet as several countries reported an increase cases 2019. In Cameroon, measles-rubella vaccination campaign was organised 2019 reduce the cohort of susceptible children. However, 2020, eleven suspected were notified Sa’a Health District five confirmed.Objective: This report summarizes outbreak...

10.4081/jphia.2021.1775 article EN cc-by Journal of Public Health in Africa 2021-06-18

<ns3:p>Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months from 2016, raising concerns whether pressure may lead selection of known parasite mutations. This study aimed at assessing profiles plasmodium falciparum dihydrofolate reductase (DHFR) dihydropteroate synthase (DHPS) gene mutations that...

10.12688/wellcomeopenres.22347.1 preprint EN cc-by Wellcome Open Research 2024-06-20

Plasmodium falciparum, the cause of most lethal malaria in humans, which still remains a threat to global health, with children and pregnant women being affected. This burden is highly pronounced areas were transmission seasonal. The emergence drug-resistance poses major obstacle control malaria. However predicting decreased or increased sensitivity anti-malarial fixation multidrug resistance genotypes vital fight against In other assess how drug policies can impact this seasonal...

10.26502/fjhs.063 article EN Fortune Journal of Health Sciences 2022-01-01

The human Cytochrome (cyp2C8) and N-acetyltransferase II (nat2) genes may vary between individuals resulting in differences anti-plasmodial treatment responses.We set out this study to determine the association cyp2C8 nat2 gene phenotypes, with failures among children uncomplicated malaria Cameroon.Treatment outcomes were assessed after, (n=235) deparasitized artemisinin based combination therapies (ACTs) (Artesunate-Amodiaquine or Sulfadoxine-Pyrimethamine-Amodiaquine) followed up for 28...

10.15406/ppij.2019.07.00244 article EN cc-by-nc Pharmacy & Pharmacology International Journal 2019-07-02

Objective: Artemisinin combination therapies(ACT) for the treatment of malaria have shown very high cure rates and with little side effects since it was introduced less that two decades ago. Continuous monitoring these drugs could  sustain this efficacy . In study we collected results from many studies evaluate safety to estimate combined 2006 2018. Methods: searched published articles databases all known websites publish articles. We also included  unpublished data dissertations. used R...

10.21955/aasopenres.1114897.1 article EN 2019-08-05
Coming Soon ...